Agilent Technologies Inc (A)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Agilent Technologies Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 7 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 138.40 $ — 60% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 15.1% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 17
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 10/31/2026 | 6.06 | 6.00 – 6.10 | 7,449 | 8.4% | 21 |
| 10/31/2027 | 6.61 | 6.36 – 6.76 | 7,901 | 9.1% | 21 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 1.48 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2025: Q1 | 1.11 | -6.40 | 1,681 | 1.40 | 18.90 | 431 | 334 |
| 2025: Q2 | 0.75 | -28.20 | 1,668 | 6.00 | 12.90 | 221 | 107 |
| 2025: Q3 | 1.18 | 21.70 | 1,738 | 10.10 | 19.30 | 362 | 259 |
| 2025: Q4 | 1.53 | 26.70 | 1,861 | 9.40 | 23.30 | 545 | 452 |
| 2026: Q1 | 1.07 | -3.10 | 1,798 | 7.00 | 17.00 | 268 | 175 |
| 2026: Q2 | 1.19 | 58.20 | 1,835 | 10.00 | 18.50 | 277 | 370 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 4,202 | 615 | 460 | 1.40 | 793 | 4,244 | 7,817 |
| 2017 | 4,472 | 841 | 684 | 2.10 | 889 | 4,826 | 8,426 |
| 2018 | 4,914 | 904 | 316 | 0.97 | 1,087 | 4,567 | 8,541 |
| 2019 | 5,163 | 941 | 1,071 | 3.37 | 1,021 | 4,748 | 9,452 |
| 2020 | 5,339 | 846 | 719 | 2.30 | 921 | 4,873 | 9,627 |
| 2021 | 6,319 | 1,347 | 1,210 | 3.94 | 1,485 | 5,389 | 10,705 |
| 2022 | 6,848 | 1,618 | 1,254 | 4.18 | 1,312 | 5,305 | 10,532 |
| 2023 | 6,833 | 1,350 | 1,240 | 4.19 | 1,772 | 5,845 | 10,763 |
| 2024 | 6,510 | 1,488 | 1,289 | 4.43 | 1,751 | 5,898 | 11,846 |
| 2025 | 6,948 | 1,479 | 1,303 | 4.59 | 1,559 | 6,741 | 12,727 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Agilent Technologies, Inc. bietet anwendungsorientierte Lösungen für die Märkte Life Sciences, Diagnostik und angewandte Chemie weltweit an.
| CEO Insider Trades (12 Mo.) | selling own stock |
|---|---|
| Employees | 18,000 |
| Headquarters | Santa Clara, CA |
| Address | 5301 Stevens Creek Boulevard, 95051 Santa Clara, United States |
| Phone | 800 227 9770 |
| Website | agilent.com |
| IPO Date | 18. Nov 1999 |
| ISIN | US00846U1016 |
| Stock Split | 1398:1000 on 11/03/2014 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Padraig McDonnell | CEO, President & Director | 1972 |
| Rodney Gonsalves | Vice President of Finance | 1966 |
| Angelica A. Riemann | Senior VP & President of Agilent CrossLab Group | 1971 |
| Simon May | Senior VP and President of Life Sciences & Diagnostics Markets Group | 1973 |
| Adam S. Elinoff | Senior VP, CFO & Principal Financial Officer | 1978 |
| Tim Downs | VP & Chief Accounting Officer | 1981 |
| August Specht Ph.D. | Senior VP & Chief Technology Officer | – |
| Tejas Rajeev Savant | Vice President of Investor Relations | – |
| Michael Buckner | Senior VP, Chief Legal Officer & Secretary | – |
| Frederick Schwarz | Senior VP, Chief Strategy & Corporate Development Officer | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.